It operates in the world of money and finance. Now — the numbers.
The company is still in the product-building phase: its spending runs far above its sales. That only changes once the product starts selling at scale.
Average growth of 8% a year over the last 4 years. Red columns mark years that ended in a loss.
Before the clock runs out, either sales must climb sharply or new money must come in. This is the most critical line in the whole picture.
Buys and sells are dead even — no clear signal either way.
The stock trades 43% below its peak. The market has trimmed its expectations for the company.
Sales run at $262 a year. A small number, but proof the product has real buyers.
A loss of $8.1M against $262 in annual sales. And on top of that, sales fell from the year before.
The stock sits at $0.50. Under exchange rules, stocks that stay below $1 for too long risk being removed from the market.
At the current pace of spending, the cash lasts less than a year. After that, the company needs to find new money.
On our five-subject report card, DSRO sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: DSRO is a high-risk stock — not yet profitable, and its future rides on its product catching on.